Variants in hormone biosynthesis genes and risk of endometrial cancer

Cancer Causes and Control

Volumn 19, Issue 9, 2008, Pages 955-963

  Olson, Sara H ^a   Orlow, Irene ^a   Bayuga, Sharon ^a   Sima, Camelia ^a   Bandera, Elisa V ^b   Pulick, Katherine ^c   Faulkner, Shameka ^d   Tommasi, Diana ^a   Egan, Daniel ^e   Roy, Pampa ^a   Wilcox, Homer ^f   Asya, Ali ^a   Modica, Ippolito ^a   Asad, Haider ^a   Soslow, Robert ^a   Zauber, Ann G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d Glencoe/McGraw Hill   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

CYP11A1; CYP17A1; CYP19A1; Endometrial cancer; Epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXON; FEMALE; GENE DELETION; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GENE;

AGED; AGED, 80 AND OVER; AROMATASE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 52549131350     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9160-7     Document Type: Article

References (45)

1. ACS (2007) Cancer facts and figures (2007) American Cancer Society, Atlanta
2. ME Sherman 2000 Theories of endometrial carcinogenesis: a multidisciplinary approach Mod Pathol 13 295 308
3. TJ Key MC Pike 1988 The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk Br J Cancer 57 205 212
4. AJ Hartz PN Barboriak A Wong KP Katayama AA Rimm 1979 The association of obesity with infertility and related menstrual abnormalities in women Int J Obes 3 57 73
5. A Jain AJ Polotsky D Rochester 2007 Pulsatile Luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women J Clin Endocrinol Metab 92 2468 2473
6. R Kaaks A Lukanova MS Kurzer 2002 Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol Biomarkers Prev 11 1531 1543
7. MA Kirschner G Schneider NH Ertel E Worton 1982 Obesity, androgens, estrogens, and cancer risk Cancer Res 42 3281s 3285s
8. PC MacDonald CD Edman DL Hemsell JC Porter PK Siiteri 1978 Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer Am J Obstet Gynecol 130 448 455
9. PK Siiteri 1981 Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer J Endocrinol 89 Suppl 119P 129P
10. JV Lacey Jr MF Leitzmann SC Chang 2007 Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort Cancer 109 1303 1311
11. BL Strom R Schinnar AL Weber 2006 Case-control study of postmenopausal hormone replacement therapy and endometrial cancer Am J Epidemiol 164 775 786
12. N Potischman RN Hoover LA Brinton 1996 Case-control study of endogenous steroid hormones and endometrial cancer J Natl Cancer Inst 88 1127 1135
13. A Lukanova E Lundin A Micheli 2004 Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women Int J Cancer 108 425 432
14. EE Calle R Kaaks 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 579 591
15. CS Healey AM Dunning F Durocher 2000 Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk Carcinogenesis 21 189 193
16. SW Baxter DY Choong DM Eccles IG Campbell 2001 Polymorphic variation in CYP19 and the risk of breast cancer Carcinogenesis 22 347 349
17. M Ronaghi 2003 Pyrosequencing for SNP genotyping Methods Mol Biol 212 189 195
18. M Franchina ME Kadin LJ Abraham 2005 Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders Cancer Epidemiol Biomarkers Prev 14 1322 1325
19. Harrell FE (2001) Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. Springer, New York
20. KY Liang SL Zeger 1986 Longitudinal data analysis using generalized linear models Biometrika 73 13 22
21. SH Olson EV Bandera I Orlow 2007 Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review Am J Epidemiol 165 235 245
22. MM Johnson J Houck C Chen 2005 Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response Cancer Epidemiol Biomarkers Prev 14 1326 1329
23. MM Gaudet JV Lacey Jr. J Lissowska 2008 Genetic variation in CYP17 and endometrial cancer risk Hum Genet 123 155 162
24. CA Haiman SE Hankinson GA Colditz DJ Hunter I De Vivo 2001 A polymorphism in CYP17 and endometrial cancer risk Cancer Res 61 3955 3960
25. AH Carey D Waterworth K Patel 1994 Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 Hum Mol Genet 3 1873 1876
26. V Nedelcheva Kristensen EK Haraldsen KB Anderson 1999 CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1 Cancer Res 59 2825 2828
27. G Jasienska M Kapiszewska PT Ellison 2006 CYP17 genotypes differ in salivary 17-beta estradiol levels: a study based on hormonal profiles from entire menstrual cycles Cancer Epidemiol Biomarkers Prev 15 2131 2135
28. NC Onland-Moret CH van Gils M Roest DE Grobbee PH Peeters 2005 CYP17, urinary sex steroid levels and breast cancer risk in postmenopausal women Cancer Epidemiol Biomarkers Prev 14 815 820
29. S Daneshmand SR Weitsman A Navab AJ Jakimiuk DA Magoffin 2002 Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters Fertil Steril 77 274 280
30. A Loukola M Chadha SG Penn 2004 Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2 Eur J Hum Genet 12 321 322
31. CF Skibola PM Bracci RA Paynter 2005 Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk Cancer Epidemiol Biomarkers Prev 14 2391 2401
32. RA Paynter SE Hankinson GA Colditz 2005 CYP19 (aromatase) haplotypes and endometrial cancer risk Int J Cancer 116 267 274
33. LM Berstein EN Imyanitov AJ Kovalevskij 2004 CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity Cancer Lett 207 191 196
34. MH Tao Q Cai ZF Zhang 2007 Polymorphisms in the CYP19A1 (Aromatase) gene and endometrial cancer risk in Chinese women Cancer Epidemiol Biomarkers Prev 16 943 949
35. CA Haiman DO Stram MC Pike 2003 A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort Hum Mol Genet 12 2679 2692
36. JR Long XO Shu Q Cai 2007 CYP19A1 genetic polymorphisms may be associated with obesity-related phenotypes in Chinese women Int J Obes (Lond) 31 418 423
37. CA Haiman L Dossus VW Setiawan 2007 Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women Cancer Res 67 1893 1897
38. www.hapmap.org, Accessed November 16 2007
39. Niu X, Burger S, Van loon S, Kohler B (2007) Cancer incidence and mortality in New Jersey 2000-2004. Cancer Epidemiology Services, New Jersey Department of Health and Senior Services
40. Ries L, Kosary C, Hankey B et al (1997) SEER cancer statistics review, 1973-1994. NIH Pub. No. 97-2789, National Cancer Institute, Bethesda
41. F Parazzini E Negri C La Vecchia 1998 Role of reproductive factors on the risk of endometrial cancer Int J Cancer 76 784 786
42. E Weiderpass HO Adami JA Baron 1999 Use of oral contraceptives and endometrial cancer risk (Sweden) Cancer Causes Control 10 277 284
43. E Weiderpass JA Baron 2001 Cigarette smoking, alcohol consumption, and endometrial cancer risk: a population-based study in Sweden Cancer Causes Control 12 239 247
44. TR Rebbeck AB Troxel Y Wang 2006 Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk J Natl Cancer Inst 98 1311 1320
45. KM Flegal MD Carroll CL Ogden CL Johnson 2002 Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 1723 1727